Biotech Values

[ThomasS]

RPRX: And the beat goes on...

http://biz.yahoo.com/bw/090127/20090127005306.html?.v=1

Repros Therapeutics Inc. Announces Information In Compliance With NASDAQ Marketplace Rule 4350
Tuesday January 27, 6:00 am ET

THE WOODLANDS, Texas--(BUSINESS WIRE)--In compliance with NASDAQ Marketplace Rule 4350(b)(1)(B), which requires any NASDAQ listed issuer that receives an audit opinion that contains a “going concern” qualification to make a public announcement to that effect through the news media, Repros Therapeutics Inc. (NasdaqGM:RPRX - News) reported today that its Annual Report on Form 10-K for the year ended December 31, 2007, included an audit opinion with a going concern qualification.

In its 2007 Annual Report on Form 10-K, the Company indicated that based on its then estimated expenses for its year 2008 planned clinical programs, it would need to raise additional capital by the fourth quarter of 2008. On October 2, 2008, the Company completed the sale of 2.4 million shares of common stock resulting in net proceeds to the Company of $15.5 million after offering expenses. As of December 31, 2008, the Company had unaudited cash and cash equivalents of $19.5 million, or $4.0 million for the year ended December 31, 2008, excluding the net proceeds of such offering.

This press release does not represent any amendment to the Company’s 2007 Annual Report on Form 10-K.